Vanderbilt-Ingram Cancer Center Archive — Page 1 of 27

June 23, 2026

Vanderbilt Health lands three of 35 Susan G. Komen research grants

Komen is the largest nonprofit funder of breast cancer research outside of the U.S. government, having invested more than $1.1 billion in research since its founding.

June 9, 2026

Vanderbilt-Ingram Cancer Center symposium tackles the factors that influence cancer development

Trainees led, planned event for second year in a row.

June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

June 2, 2026

Resilient Stage 4 colon cancer patient discovers surgery option close to home  

Vanderbilt-Ingram Cancer Center is “pushing the envelope” with new technologies like histotripsy and new programs like robotic liver surgery and robotic pancreas surgery, serving patients not only from Tennessee, but also parts of Kentucky, Alabama and Georgia.  

May 14, 2026

Vanderbilt-Ingram Cancer Center names co-leaders for Thoracic Oncology Program

Together, the co-leaders bring complementary expertise aimed at delivering the most innovative and advanced options for patients at all stages of lung and other thoracic cancers.

(iStock)
April 22, 2026

Liquid biopsy predicts response to breast cancer immunotherapy

This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.